Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Removing both ovaries triggers an abrupt drop in estrogen that can accelerate bone loss within months, causing some women to lose up to 20 percent of bone density in the first few years after surgery. Because estrogen normally restrains the cells that break down bone, surgical menopause raises fracture and osteoporosis risk faster than natural menopause, especially before age 45, which is why endocrinologists recommend baseline DEXA scanning, adequate calcium and vitamin D, weight-bearing exercise, and prompt discussion of hormone therapy or bone-specific medication. Timing, your age at surgery, and personal risk factors all change the plan, so there are important details to consider below before deciding on next steps.
If you have had an oophorectomy or are preparing for one and notice symptoms such as bone or joint pain, height loss, hot flashes, or fatigue, a free, instant, online symptom check can help you organize what you are experiencing in minutes. Knowing which signs point to hormone-related bone loss makes your next conversation with an endocrinologist far more productive, so take a moment to check your symptoms and move forward with clarity.
Last reviewed for medical accuracy: 08/18/2026
Undergoing an oophorectomy—the surgical removal of one or both ovaries—brings benefits for certain conditions (endometriosis, ovarian cancer risk reduction, severe pain), but it also triggers early surgical menopause. A sudden drop in estrogen dramatically accelerates bone density loss in early surgical menopause. This guide explains why acting promptly to protect your bones is crucial, and outlines steps you and your endocrinologist can take to maintain long-term skeletal health.
Estrogen plays a key role in maintaining bone strength. When ovaries are removed:
Studies show women who undergo oophorectomy before natural menopause lose bone mineral density (BMD) two to three times faster than those experiencing gradual, natural menopause. This bone density loss in early surgical menopause translates into a 5–10% drop in BMD within the first year—heightening fracture risk decades before most women would naturally face it.
While oophorectomy itself is the primary driver, other factors influence the speed and severity of BMD decline:
Identifying and modifying these factors early can meaningfully slow bone loss.
“Osteoporosis prevention” isn’t a concern you can safely postpone after an oophorectomy. Because bone loss occurs so rapidly:
Early intervention preserves peak bone mass and sets a foundation for healthier aging.
Your endocrinologist will tailor a plan based on age, risk profile, and personal preferences. Common approaches include:
Note: HT may not suit everyone (e.g., those with certain clotting disorders or breast cancer history). Your doctor will weigh benefits and risks.
Bone-protective treatments work best when combined with healthy habits:
Regular check-ups allow your endocrinologist to adjust therapy as needed:
Even with proactive measures, stay alert for symptoms that could indicate advancing bone issues or other complications:
You might consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker (https://ubiehealth.com/). This quick tool can help you decide if you need a prompt medical evaluation.
Oophorectomy may be necessary for health reasons, but early surgical menopause carries a significant risk of bone density loss. Immediate, comprehensive bone protection—through hormone therapy, medications, lifestyle changes, and close monitoring—can safeguard your skeletal health for decades to come. Talk openly with your endocrinologist about your personal risk factors and the best prevention plan for you.
If you experience any serious or life-threatening symptoms following oophorectomy, speak to a doctor right away. Your healthcare team is your partner in navigating these changes and ensuring the best possible outcome.
(References)
* Clines GA, Choksi P, Van Poznak C. Adjuvant Endocrine Therapy and Bone Health in Breast Cancer. Curr Osteoporos Rep. 2015 Oct;13(5):263-73. doi: 10.1007/s11914-015-0277-9. PMID: 26209043.
* Shen G, Ren H, Shang Q, Zhao W, Zhang Z, Yu X, Tang K, Tang J, Yang Z, Liang D, Jiang X. Foxf1 knockdown promotes BMSC osteogenesis in part by activating the Wnt/β-catenin signalling pathway and prevents ovariectomy-induced bone loss. EBioMedicine. 2020 Feb;52:102626. doi: 10.1016/j.ebiom.2020.102626. Epub 2020 Jan 22. PMID: 31981979; PMCID: PMC6992955.
* Sobecki JN, Rice LW, Hartenbach EM. Bone health and osteoporosis screening in gynecologic cancer survivors. Gynecol Oncol. 2021 Feb;160(2):619-624. doi: 10.1016/j.ygyno.2020.11.028. Epub 2020 Dec 11. PMID: 33309416.
* Guan Z, Xuanqi Z, Zhu J, Yuan W, Jia J, Zhang C, Sun T, Leng H, Jiang C, Xu Y, Song C. Estrogen deficiency induces bone loss through the gut microbiota. Pharmacol Res. 2023 Oct;196:106930. doi: 10.1016/j.phrs.2023.106930. Epub 2023 Sep 16. PMID: 37722518.
* Franco FSC, Natali AJ, Costa NMB. Caffeine and Ovariectomy Debilitate Bone Health in Rats on Calcium-deficient Diet. An Acad Bras Cienc. 2024;96(suppl 1):e20230095. doi: 10.1590/0001-3765202420230095. Epub 2024 Aug 5. PMID: 39109696.
* Billig H, Schmitt J, Singer L, Bourauel C, Schildberg FA, Masson W, Lübbering N, Vogel W, Perner S, Stei M, Niepmann S, Silaschi M, Bakhtiary F, Nickenig G, Zimmer S. Aortic valve stenosis and osteoporosis: insights from a mouse model. BMC Cardiovasc Disord. 2025 Jul 31;25(1):562. doi: 10.1186/s12872-025-05037-4. Epub 2025 Jul 31. PMID: 40745526; PMCID: PMC12312273.
* Pan C, Li S, Li C, Ko WC, Liu T, Liu H, Guo D, Ding Y. Fabkin Promoted Osteoclasts Mature and Bone Loss in OVX-Induced Osteoporosis Mice. FASEB J. 2025 Sep 30;39(18):e71028. doi: 10.1096/fj.202501946R. PMID: 40965974.
* Beekman MJ, Terra L, Stuursma A, Heemskerk-Gerritsen BAM, van Lennep JER, van Beurden M, van Doorn LC, de Hullu JA, van Dorst EBL, Mom CH, Slangen BFM, Mitea C, Slart RHJA, Snoeren MM, Stokkel MP, Verberne HJ, de Keizer B, Korse CM, Gaarenstroom KN, van Engelen K, van der Kolk LE, Collée JM, Wevers MR, Ausems MGEM, Berger LPV, Garcia EBG, van Asperen CJ, Hooning MJ, Maas AHEM, Mourits MJE, van Leeuwen FE, Zillikens MC. Long-term effects of premenopausal risk-reducing salpingo-oophorectomy on bone mineral density. Osteoporos Int. 2025 Nov;36(11):2307-2317. doi: 10.1007/s00198-025-07679-8. Epub 2025 Oct 4. PMID: 41045325; PMCID: PMC12628374.
* Guo Y, He L, Xue A, Sun Y, Liu R, Zhang M, Liu Y, Yu F, Guo P, Zhao Y, Tang L, Li X, Lu W, Li Y, Sun P. Exercise increases bone mass by lactate/Gpr81 signaling pathway. Commun Biol. 2025 Nov 10;8(1):1548. doi: 10.1038/s42003-025-08957-1. Epub 2025 Nov 10. PMID: 41214246; PMCID: PMC12603139.
* Akbaş B, Dinç G, Akbaş A, Hacım NA, Ercan G, Aygün H, Erbaş O. Sodium Phenylbutyrate Ameliorates Ovariectomy-Induced Bone Loss in Rats. Medicina (Kaunas). 2025 Nov 11;61(11). doi: 10.3390/medicina61112016. Epub 2025 Nov 11. PMID: 41303852; PMCID: PMC12654267.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.